Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

The de novo synthesis of GABA and its gene regulatory function control hepatocellular carcinoma metastasis.

Li Li | Youli Kang | Running Cheng | Fangming Liu | Fujia Wu | Zizhao Liu | Junjie Kou | Zhenxi Zhang | Wei Li | Haitao Zhao | Xiaojing He | Wenjing Du
Developmental cell | 2024

The neurotransmitter gamma-aminobutyric acid (GABA) has been thought to be involved in the development of some types of cancer. Yet, the de novo synthesis of GABA and how it functions in hepatocellular carcinoma (HCC) remain unclear. Here, we report that SLC6A12 acts as a transporter of GABA, and that aldehyde dehydrogenase 9 family member A1 (ALDH9A1), not glutamate decarboxylase 1 (GAD1), generates GABA in human HCC. Interestingly, SLC6A12 and ALDH9A1 are upregulated during lung metastases of HCC, and depletion of either of them leads to impaired HCC metastasis. Mechanistically, GABA directly binds and stabilizes β-catenin, resulting in activated Wnt/β-catenin signaling, and thereby enhancing HCC metastasis. Reciprocally, β-catenin transcriptionally upregulates SLC6A12 to import more GABA to stabilize β-catenin. Thus, our findings identify ALDH9A1 as the major GABA synthetase in HCC, demonstrate a positive-feedback regulatory mechanism for sustaining Wnt/β-catenin signaling, and reveal a role for β-catenin in sensing GABA, which contributes to HCC metastasis.

Pubmed ID: 39740661

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Phospho-beta-Catenin (Ser33/37/Thr41) Antibody (antibody)

RRID:AB_331729

This polyclonal targets Phospho-beta-Catenin (Ser33/37/Thr41)

View all literature mentions

β-Catenin (D10A8) XP® Rabbit mAb (antibody)

RRID:AB_11127855

This monoclonal targets β-Catenin

View all literature mentions

Anti-β-Actin Monoclonal antibody (antibody)

RRID:AB_3065784

This monoclonal targets β-Actin

View all literature mentions

Epithelial-Mesenchymal Transition (EMT) Antibody Sampler Kit (antibody)

RRID:AB_10828222

This unknown targets Epithelial-Mesenchymal Transition (EMT) Sampler Kit

View all literature mentions

Anti-β-Tubulin Monoclonal antibody (antibody)

RRID:AB_3065792

This monoclonal targets β-Tubulin

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions